Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.39 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.39 |
| ▸ | TET3 | O43151 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839524 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL3776280 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL3781040 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL6838462 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL13062508 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL14643178 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL13015306 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL640339 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL3776284 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 | |
| SCHEMBL8573155 | 1.00 | OR51E2 (0.57) | OR51E2PDE4AUSP2SLCO1B1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344985-A | Genetically engineered bacterium for producing additional value products based on glucose, construction method and application | 浙江大学杭州国际科创中心 | 2024-07-16 | — | — | CN | claimed |
| US-20040254368-A1 | Production of aldoses | MITSUI CHEMICALS, INC. (JP) | 2004-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254368-A1 | Production of aldoses | ALDOA, ADH1C, AKR1C1 | OR51E2 2750/4885PDE4A 4298/4885USP2 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.